Insight Molecular Diagnostics (IMDX) Interest Coverage Ratio (QoQ) (2017 - 2026)
Insight Molecular Diagnostics (IMDX) Interest Coverage Ratio (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.60 Mn | 143.67 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.09% |
| Dec 31, 2025 | -1,081.58% |
| Sep 30, 2025 | -147.70% |
| Jun 30, 2025 | 63.38% |
| Mar 31, 2025 | 94.49% |
| Dec 31, 2024 | -7,021.55% |
| Sep 30, 2024 | 79.43% |
| Jun 30, 2024 | -13.77% |
| Mar 31, 2024 | 80.55% |
| Dec 31, 2023 | 82.31% |
| Sep 30, 2023 | -57.05% |
| Jun 30, 2023 | -754.01% |
| Mar 31, 2023 | 150.75% |
| Dec 31, 2022 | -8,915.36% |
| Sep 30, 2022 | -4.92% |
| Jun 30, 2022 | 46.11% |
| Mar 31, 2022 | 99.39% |
| Dec 31, 2021 | -3,573.75% |
| Sep 30, 2021 | 91.45% |
| Jun 30, 2021 | -2,158.47% |